| 000 | 01910 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516212205.0 | ||
| 264 | 0 | _c20150115 | |
| 008 | 201501s 0 0 eng d | ||
| 022 | _a1791-2423 | ||
| 024 | 7 |
_a10.3892/ijo.2014.2423 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHsu, Fei-Ting | |
| 245 | 0 | 0 |
_aSorafenib increases efficacy of vorinostat against human hepatocellular carcinoma through transduction inhibition of vorinostat-induced ERK/NF-κB signaling. _h[electronic resource] |
| 260 |
_bInternational journal of oncology _cJul 2014 |
||
| 300 |
_a177-88 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aAntineoplastic Combined Chemotherapy Protocols |
| 650 | 0 | 4 |
_aCarcinoma, Hepatocellular _xpathology |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxamic Acids _xadministration & dosage |
| 650 | 0 | 4 |
_aLiver Neoplasms _xpathology |
| 650 | 0 | 4 | _aLiver Neoplasms, Experimental |
| 650 | 0 | 4 |
_aMAP Kinase Signaling System _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Nude |
| 650 | 0 | 4 |
_aNiacinamide _xadministration & dosage |
| 650 | 0 | 4 |
_aPhenylurea Compounds _xadministration & dosage |
| 650 | 0 | 4 |
_aProtein Serine-Threonine Kinases _xmetabolism |
| 650 | 0 | 4 | _aSorafenib |
| 650 | 0 | 4 | _aVorinostat |
| 650 | 0 | 4 | _aXenograft Model Antitumor Assays |
| 650 | 0 | 4 | _aNF-kappaB-Inducing Kinase |
| 700 | 1 | _aLiu, Yu-Chang | |
| 700 | 1 | _aChiang, I-Tsang | |
| 700 | 1 | _aLiu, Ren-Shyan | |
| 700 | 1 | _aWang, Hsin-Ell | |
| 700 | 1 | _aLin, Wuu-Jyh | |
| 700 | 1 | _aHwang, Jeng-Jong | |
| 773 | 0 |
_tInternational journal of oncology _gvol. 45 _gno. 1 _gp. 177-88 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3892/ijo.2014.2423 _zAvailable from publisher's website |
| 999 |
_c23805439 _d23805439 |
||